Phase 2CompletedAge-related condition
Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension (FELT)
Randomized, Parallel Group, Double-blind Trial to Evaluate Different Dose Combinations of Lercanidipine and Enalapril in Comparison With Each Component Administered Alone and With Placebo in Patients With Essential Hypertension
- Sponsor
- RECORDATI GROUP (Industry)
- Enrollment
- 1,039 enrolled
- Conditions
- Essential Hypertension
- Interventions
- Placebo; Lercanidipine; Lercanidipine; Enalapril; Enalapril; Lercanidipine + Enalapril; Lercanidipine + Enalapril; Lercanidipine + Enalapril; Lercanidipine + Enalapril
- Ages
- adults, older adults
- Registry
- NCT01093807
Full record on ClinicalTrials.gov
From the registry
The purpose of this study is to evaluate the efficacy and safety of various dosage combinations of lercanidipine (10 and 20 mg)and enalapril (10 and 20 mg) in comparison with their respective components and with placebo.
Primary outcomes
- Change from baseline in sitting diastolic blood pressure (SDBP)
History
Last registry update
Study completion
Primary completion
Registered
Started